Home/Filings/4/0001140361-24-035583
4//SEC Filing

van Gunsteren Job Leonard 4

Accession 0001140361-24-035583

CIK 0000009326other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 6:08 PM ET

Size

12.0 KB

Accession

0001140361-24-035583

Insider Transaction Report

Form 4
Period: 2024-07-31
van Gunsteren Job Leonard
SVP and GM, Specialty Products
Transactions
  • Exercise/Conversion

    Common Stock

    2024-07-31$58.52/sh+4,000$234,08012,540 total
  • Sale

    Common Stock

    2024-07-31$180.05/sh7,750$1,395,4128,540 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-07-314,0000 total
    Exercise: $58.52Exp: 2025-02-19Common Stock (4,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-07-313,7500 total
    Exercise: $60.85Exp: 2026-02-23Common Stock (3,750 underlying)
  • Exercise/Conversion

    Common Stock

    2024-07-31$60.85/sh+3,750$228,18816,290 total
Footnotes (4)
  • [F1]Exercise of fully vested non-qualified stock options.
  • [F2]This transaction was executed in multiple sales ranging from $180.0000 to $180.5300 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote
  • [F3]Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable.
  • [F4]Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001906287

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 6:08 PM ET
Size
12.0 KB